Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00401-016-1545-1.

Title:
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Acta Neuropathologica
Description:
The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor. For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era. As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M–mutant; RELA fusion–positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered. The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance. Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma—a departure from the manner by which other CNS tumors are graded. Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

tumors, pubmed, tumor, classification, cns, article, diffuse, google, scholar, molecular, idh, grade, astrocytoma, genetic, features, central, gliomas, brain, histological, glioblastoma, diagnosis, neuropathol, acta, cas, entities, diagnostic, anaplastic, defined, cancer, oligodendroglioma, university, idhmutant, grading, glioblastomas, cells, expression, nos, entity, diagnoses, clinical, table, research, solitary, fibrous, cases, idhwildtype, glioma, ependymoma, similar, mutation,

Topics {✒️}

nf-kappab signaling pathway post-contrast t1 mri kees kleihues-van tol recurrent nab2-stat6 fusion atypical teratoid/rhabdoid tumor perivascular virchow-robin spaces central nervous system neuro-oncological clinical advisors pediatric low-grade gliomas copy-number profiling identify h3 k27–mutant protein full size image atypical teratoid/rhabdoid tumors false-positive fish results lysosome-rich tumor cells diffuse lower-grade gliomas nerve sheath tumors large cell/anaplastic features rela fusion–positive ependymoma ep-gbms show features partner site essen/duesseldorf andreas von deimling false-negative atrx immunostaining 1p/19q-codeleted includes phenotype–genotype correlation grows mixed neuronal-glial tumours van thuijl hf increased cell size 1p/19q codeletion status idh-wildtype epithelioid glioblastomas anaplastic-level diffuse gliomas tert promoter mutations including idh-mutant astrocytic rodriguez fj combined phenotypic–genotypic diagnostics privacy choices/manage cookies hematopoietic/lymphoid pathology community eastern cancer registration cell–cell wrapping t2-weighted mri rela fusion–positive rela fusion–positive [33 adult malignant gliomas c19mc-amplified tumors include idh-mutant cases appears low-grade precursor erasmus medical center exome sequencing identifies shh/wnt molecular subgroups solitary fibrous tumor

Questions {❓}

  • Alexandrescu S, Korshunov A, Lai SH, Dabiri S, Patil S, Li R, Shih CS, Bonnin JM, Baker JA, Du E et al (2015) Epithelioid glioblastomas and anaplastic epithelioid pleomorphic xanthoastrocytomas—same entity or first cousins?
  • Huse JT, Diamond EL, Wang L, Rosenblum MK (2015) Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true “oligoastrocytoma”?
  • Louis DN (2012) The next step in brain tumor classification: “Let us now praise famous men”… or molecules?
  • Wilcox P, Li CC, Lee M, Shivalingam B, Brennan J, Suter CM, Kaufman K, Lum T, Buckland ME (2015) Oligoastrocytomas: throwing the baby out with the bathwater?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
         description:The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor. For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era. As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M–mutant; RELA fusion–positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered. The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance. Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma—a departure from the manner by which other CNS tumors are graded. Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.
         datePublished:2016-05-09T00:00:00Z
         dateModified:2016-05-09T00:00:00Z
         pageStart:803
         pageEnd:820
         sameAs:https://doi.org/10.1007/s00401-016-1545-1
         keywords:
            Astrocytoma
            Medulloblastoma
            Oligodendroglioma
            Pilocytic Astrocytoma
            Malignant Peripheral Nerve Sheath Tumor
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig5_HTML.jpg
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:131
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:David N. Louis
               affiliation:
                     name:Harvard Medical School
                     address:
                        name:Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Arie Perry
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Pathology, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guido Reifenberger
               affiliation:
                     name:Heinrich Heine University
                     address:
                        name:Department of Neuropathology, Heinrich Heine University, Duesseldorf, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Consortium (DKTK)
                     address:
                        name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andreas von Deimling
               affiliation:
                     name:German Cancer Consortium (DKTK)
                     address:
                        name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
                        type:PostalAddress
                     type:Organization
                     name:Ruprecht-Karls-University
                     address:
                        name:Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dominique Figarella-Branger
               affiliation:
                     name:Aix Marseille University
                     address:
                        name:Department of Pathology and Neuropathology, La Timone Hospital, Aix Marseille University, Marseille, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Webster K. Cavenee
               affiliation:
                     name:University of California San Diego
                     address:
                        name:Ludwig Institute for Cancer Research, University of California San Diego, San Diego, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroko Ohgaki
               affiliation:
                     name:International Agency for Research on Cancer (IARC)
                     address:
                        name:International Agency for Research on Cancer (IARC), Lyon, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Otmar D. Wiestler
               affiliation:
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paul Kleihues
               affiliation:
                     name:University of Zurich
                     address:
                        name:Medical Faculty, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David W. Ellison
               affiliation:
                     name:St. Jude Children’s Research Hospital
                     address:
                        name:Department of Pathology, St. Jude Children’s Research Hospital, Memphis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
      description:The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor. For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era. As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M–mutant; RELA fusion–positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered. The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance. Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma—a departure from the manner by which other CNS tumors are graded. Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.
      datePublished:2016-05-09T00:00:00Z
      dateModified:2016-05-09T00:00:00Z
      pageStart:803
      pageEnd:820
      sameAs:https://doi.org/10.1007/s00401-016-1545-1
      keywords:
         Astrocytoma
         Medulloblastoma
         Oligodendroglioma
         Pilocytic Astrocytoma
         Malignant Peripheral Nerve Sheath Tumor
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1545-1/MediaObjects/401_2016_1545_Fig5_HTML.jpg
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:131
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:David N. Louis
            affiliation:
                  name:Harvard Medical School
                  address:
                     name:Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Arie Perry
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Pathology, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guido Reifenberger
            affiliation:
                  name:Heinrich Heine University
                  address:
                     name:Department of Neuropathology, Heinrich Heine University, Duesseldorf, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Consortium (DKTK)
                  address:
                     name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andreas von Deimling
            affiliation:
                  name:German Cancer Consortium (DKTK)
                  address:
                     name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
                     type:PostalAddress
                  type:Organization
                  name:Ruprecht-Karls-University
                  address:
                     name:Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dominique Figarella-Branger
            affiliation:
                  name:Aix Marseille University
                  address:
                     name:Department of Pathology and Neuropathology, La Timone Hospital, Aix Marseille University, Marseille, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Webster K. Cavenee
            affiliation:
                  name:University of California San Diego
                  address:
                     name:Ludwig Institute for Cancer Research, University of California San Diego, San Diego, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroko Ohgaki
            affiliation:
                  name:International Agency for Research on Cancer (IARC)
                  address:
                     name:International Agency for Research on Cancer (IARC), Lyon, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Otmar D. Wiestler
            affiliation:
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paul Kleihues
            affiliation:
                  name:University of Zurich
                  address:
                     name:Medical Faculty, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David W. Ellison
            affiliation:
                  name:St. Jude Children’s Research Hospital
                  address:
                     name:Department of Pathology, St. Jude Children’s Research Hospital, Memphis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:131
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Harvard Medical School
      address:
         name:Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Pathology, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:Heinrich Heine University
      address:
         name:Department of Neuropathology, Heinrich Heine University, Duesseldorf, Germany
         type:PostalAddress
      name:German Cancer Consortium (DKTK)
      address:
         name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
         type:PostalAddress
      name:German Cancer Consortium (DKTK)
      address:
         name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
         type:PostalAddress
      name:Ruprecht-Karls-University
      address:
         name:Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany
         type:PostalAddress
      name:Aix Marseille University
      address:
         name:Department of Pathology and Neuropathology, La Timone Hospital, Aix Marseille University, Marseille, France
         type:PostalAddress
      name:University of California San Diego
      address:
         name:Ludwig Institute for Cancer Research, University of California San Diego, San Diego, USA
         type:PostalAddress
      name:International Agency for Research on Cancer (IARC)
      address:
         name:International Agency for Research on Cancer (IARC), Lyon, France
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:University of Zurich
      address:
         name:Medical Faculty, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:St. Jude Children’s Research Hospital
      address:
         name:Department of Pathology, St. Jude Children’s Research Hospital, Memphis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:David N. Louis
      affiliation:
            name:Harvard Medical School
            address:
               name:Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Arie Perry
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Pathology, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Guido Reifenberger
      affiliation:
            name:Heinrich Heine University
            address:
               name:Department of Neuropathology, Heinrich Heine University, Duesseldorf, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Consortium (DKTK)
            address:
               name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
               type:PostalAddress
            type:Organization
      name:Andreas von Deimling
      affiliation:
            name:German Cancer Consortium (DKTK)
            address:
               name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
               type:PostalAddress
            type:Organization
            name:Ruprecht-Karls-University
            address:
               name:Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Dominique Figarella-Branger
      affiliation:
            name:Aix Marseille University
            address:
               name:Department of Pathology and Neuropathology, La Timone Hospital, Aix Marseille University, Marseille, France
               type:PostalAddress
            type:Organization
      name:Webster K. Cavenee
      affiliation:
            name:University of California San Diego
            address:
               name:Ludwig Institute for Cancer Research, University of California San Diego, San Diego, USA
               type:PostalAddress
            type:Organization
      name:Hiroko Ohgaki
      affiliation:
            name:International Agency for Research on Cancer (IARC)
            address:
               name:International Agency for Research on Cancer (IARC), Lyon, France
               type:PostalAddress
            type:Organization
      name:Otmar D. Wiestler
      affiliation:
            name:German Cancer Research Center (DKFZ)
            address:
               name:German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Paul Kleihues
      affiliation:
            name:University of Zurich
            address:
               name:Medical Faculty, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:David W. Ellison
      affiliation:
            name:St. Jude Children’s Research Hospital
            address:
               name:Department of Pathology, St. Jude Children’s Research Hospital, Memphis, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
      name:Department of Pathology, University of California San Francisco, San Francisco, USA
      name:Department of Neuropathology, Heinrich Heine University, Duesseldorf, Germany
      name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
      name:German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, Germany
      name:Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany
      name:Department of Pathology and Neuropathology, La Timone Hospital, Aix Marseille University, Marseille, France
      name:Ludwig Institute for Cancer Research, University of California San Diego, San Diego, USA
      name:International Agency for Research on Cancer (IARC), Lyon, France
      name:German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Medical Faculty, University of Zurich, Zurich, Switzerland
      name:Department of Pathology, St. Jude Children’s Research Hospital, Memphis, USA

External Links {🔗}(228)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.45s.